Michael Jacob Chi-Wing Yong, MD
Otolaryngology · Los Angeles
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Providence Saint Johns Medical Foundation · 282 clinicians in this group
Hospitals listed: Providence Little Company of Mary Med Ctr Torrance · Saint John'S Health Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Yong’s office at (310) 477-5558 to ask if they take your plan before you enroll.
California Medical Board record
Licence A176533 · Current
Licensed to practise in California · since 2022 · expires 2028-02-29 · University of British Columbia Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Providence Little Company of Mary Med Ctr TorranceTorrance, CAAcute Care Hospital · Voluntary non-profit - Church · No emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.472, Oct 2024 – Sep 2025
- Saint John'S Health CenterSanta Monica, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 73% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — SSI - Colon Surgery: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Providence Little Company of Mary Med Ctr Torrance
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 8 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.472 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.09 (0.11 to 2.07) · 1,022 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.59 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 129.31 (75.73 to 182.88) · 65 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 36 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 70 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.4 · 353 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.2 · 361 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 495 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 3,150 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.39) · 5,786 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.06 to 0.45) · 5,832 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.21 (2.1 to 6.32) · 1,135 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.81 (0.22 to 3.4) · 375 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.8 to 3.86) · 1,086 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.78 (2.28 to 15.28) · 389 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.58 (1.19 to 7.98) · 377 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2 (0.51 to 3.49) · 247 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.3 (0 to 0.93) · 4,918 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 127 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.892 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.225 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.363 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 283 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 709 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 10.5 · 149 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 7.9 · 428 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -13.8 · 369 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 551 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 130 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.7 · 59 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 168 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.8 (8.9 to 15.5) · 642 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 331 cases | No different | Jan 2024 – Dec 2024 |
What patients said (414 patients answered, 18% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
See every measure and the patient survey for Saint John'S Health Center
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.64 (0 to 1.49) · 1,939 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.6 to 1.12) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 140.49 (93.64 to 187.34) · 101 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 33 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.7 · 101 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.1 · 175 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.4 · 412 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11 · 615 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.3 · 317 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 3,461 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.03 to 0.42) · 8,758 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.18 (0 to 0.36) · 9,150 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.57 (0.92 to 4.22) · 3,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.03 to 3.91) · 2,439 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.7 (0.39 to 3) · 3,369 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.55 (3.36 to 13.74) · 2,341 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.38 (3.53 to 9.24) · 2,433 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.52 (0.1 to 2.94) · 677 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.25 (0 to 0.81) · 6,775 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.3 · 945 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.631 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.6 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 1.069 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.268 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14 · 174 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.8 · 434 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.3 · 178 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 1.3 · 458 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.4 · 646 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17 · 605 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.6 (3.1 to 6.8) · 246 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.6 (7.7 to 14.4) · 246 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 3.5 · 907 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.1 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.9 (9 to 15.8) · 258 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 955 cases | No different | Jan 2024 – Dec 2024 |
What patients said (450 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 71% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 78% |
| Yes, staff "did" give patients information about help after discharge | 77% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 77% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 73% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 79% |
Original Medicare doctor bills
$251,953
Medicare paid this office $251,953 for 720 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Diagnostic exam of nasal passages using an endoscope | 268 | $56,581 | $163 |
| Return visit (30+ min) | 182 | $25,138 | $100 |
| New patient visit (45+ min) | 151 | $19,114 | $127 |
| Short return visit (20+ min) | 180 | $17,336 | $73 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 28 | $12,956 | $288 |
See all 14 services
| Diagnostic exam of nasal passages using an endoscope | 268 | $56,581 | $163 |
| Return visit (30+ min) | 182 | $25,138 | $100 |
| New patient visit (45+ min) | 151 | $19,114 | $127 |
| Short return visit (20+ min) | 180 | $17,336 | $73 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 28 | $12,956 | $288 |
| New patient visit (30+ min) | 142 | $12,080 | $85 |
| Removal of impacted ear wax | 222 | $8,971 | $35 |
| Diagnostic exam of voice box using a flexible endoscope | 40 | $4,653 | $113 |
| Control of bleeding of nose using an endoscope | 19 | $4,484 | $214 |
| Short return visit | 55 | $2,866 | $45 |
| New patient visit (15+ min) | 47 | $2,393 | $51 |
| New patient visit (60+ min) | 12 | $2,247 | $187 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 121 | $1,959 | $14 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $1,174 | $78 |
Who their Medicare patients are
720 Original Medicare patients in 2024. Average age 77 · Under 65 2% · 85 and older 17% · Women 59% · Also on Medicaid 11% · Health risk score 1.11. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 67% · Coronary heart disease 36% · Diabetes 23% · Depression 20% · Cancer 17% · Atrial fibrillation 16% · Chronic kidney disease 14% · Heart failure 13% · COPD 12% · Stroke 11% · Dementia 8%.
The office billed $1,568,251, Medicare allowed $330,350 and paid $251,953; for 2,067 services of 66 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 720 | 2,067 | 77 | 1.11 | $1,568,251 | $251,953 |
| 2023 | 495 | 976 | 76 | 1.18 | $542,749 | $93,432 |
| 2022 | 79 | 145 | 71 | 1.28 | $38,406 | $10,520 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Diagnostic exam of nasal passages using an endoscope | 117 | $22,159 | $172 |
| Short return visit (20+ min) | 77 | $8,066 | $78 |
| Removal of impacted ear wax | 169 | $7,864 | $39 |
| Return visit (30+ min) | 58 | $7,526 | $109 |
| New patient visit (45+ min) | 46 | $6,456 | $140 |
| New patient visit (30+ min) | 56 | $5,324 | $95 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 20 | $4,023 | $192 |
| Short return visit | 61 | $3,171 | $50 |
| Diagnostic exam of voice box using a flexible endoscope | 26 | $2,939 | $113 |
| New patient visit (15+ min) | 40 | $2,384 | $60 |
| Exam to assess movement of vocal cord flaps using an endoscope | 11 | $1,780 | $162 |
| Diagnostic exam of nasal passages using an endoscope | 59 | $1,351 | $22 |
| Short return visit (20+ min) | 20 | $1,133 | $54 |
| New patient visit (45+ min) | 11 | $1,131 | $103 |
| Return visit (30+ min) | 12 | $752 | $63 |
2022: 5 services
| Biopsy or removal of nasal polyp or tissue using an endoscope | 12 | $2,491 | $192 |
| Diagnostic exam of nasal passages using an endoscope | 60 | $1,533 | $25 |
| New patient visit (45+ min) | 12 | $1,460 | $122 |
| Return visit (30+ min) | 16 | $1,437 | $90 |
| Short return visit (20+ min) | 22 | $1,270 | $58 |
Drugs they prescribed that Part D paid
$31,915
Pharmacies billed $31,915 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (25 of 925) in 2024. At or below the middle of the specialty; the typical otolaryngology clinician is at 4%.
874 generic and 51 brand-name prescriptions · $31,915 in drug cost · 42 antibiotic prescriptions to 36 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ipratropium | 73 | $6,263 | $35 |
| Azelastine | 125 | $5,729 | $24 |
| Ciprofloxacin-Dexamethasone | 32 | $5,508 | $128 |
| Lansoprazole | 43 | $2,710 | $46 |
| Fluocinolone Acetonide Oil | 29 | $1,578 | $33 |
See all 13 drugs
| Ipratropium | 73 | $6,263 | $35 |
| Azelastine | 125 | $5,729 | $24 |
| Ciprofloxacin-Dexamethasone | 32 | $5,508 | $128 |
| Lansoprazole | 43 | $2,710 | $46 |
| Fluocinolone Acetonide Oil | 29 | $1,578 | $33 |
| Fluticasone Propionate | 33 | $812 | $14 |
| Mupirocin | 51 | $444 | $8 |
| Amoxicillin-Clavulanate Potass | 26 | $309 | $10 |
| Oxycodone-Acetaminophen | 21 | $152 | $7 |
| Gabapentin | 13 | $109 | $7 |
| Prednisone | 21 | $99 | $5 |
| Methylprednisolone | 15 | $88 | $6 |
| Lorazepam | 12 | $20 | $1 |
Year by year
| 2024 | 925 | 379 | 3% (25) | 6% | $31,915 |
| 2023 | 362 | 191 | 3% (11) | 7% | $40,711 |
| 2022 | 59 | 35 | None | None | $3,342 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Azelastine | 82 | $2,378 | $29 |
| Ciprofloxacin-Dexamethasone | 13 | $2,128 | $164 |
| Ipratropium | 53 | $2,004 | $38 |
| Lansoprazole | 28 | $1,233 | $44 |
| Fluocinolone Acetonide Oil | 21 | $1,162 | $55 |
| Fluticasone Propionate | 26 | $534 | $21 |
| Mupirocin | 30 | $246 | $8 |
| Amoxicillin-Clavulanate Potass | 17 | $225 | $13 |
2022: 2 drugs
| Azelastine | 12 | $653 | $54 |
| Fluticasone Propionate | 11 | $116 | $11 |
Money from drug and device companies
$3,560 in 2025
| 2025 | 8 | 17 | $2,600 | $3,560 |
| 2024 | 9 | 34 | $2,608 | $5,051 |
| 2023 | 5 | 6 | $300 | $542 |
| 2022 | 4 | 6 | None | $351 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Aerin Medical | Vivaer Stylus | $3,033 | 6 payments
|
| Integra LifeSciences | Acclarent Aera | $148 | 1 payment
|
| GlaxoSmithKline | Nucala | $126 | 4 payments
|
| Axogen | None | $119 | 1 payment
|
| Genzyme | Dupixent | $54 | 2 payments
|
| Merz Pharmaceuticals | Xeomin | $46 | 1 payment
|
See all 17 published payments
| Genzyme | Meals · 2025-11-18 | Dupixent | $30 |
| Aerin Medical | Meals · 2025-09-16 | Vivaer Stylus | $149 |
| GlaxoSmithKline | Meals · 2025-08-26 | Nucala | $34 |
| Optinose US | Meals · 2025-08-04 | Xhance | $17 |
| Integra LifeSciences | Meals · 2025-07-11 | Acclarent Aera | $148 |
| Aerin Medical | Consulting · 2025-07-11 | Vivaer Stylus | $400 |
| GlaxoSmithKline | Meals · 2025-05-13 | Nucala | $32 |
| Aerin Medical | Travel · 2025-04-29 | Vivaer Stylus | $276 |
| Aerin Medical | Consulting · 2025-04-29 | Vivaer Stylus | $600 |
| Aerin Medical | Consulting · 2025-04-29 | Vivaer Stylus | $1,600 |
| Aerin Medical | Meals · 2025-04-29 | Vivaer Stylus | $8 |
| Genzyme | Meals · 2025-04-08 | Dupixent | $24 |
| GlaxoSmithKline | Meals · 2025-03-26 | Nucala | $31 |
| MDD US Operations | Meals · 2025-03-05 | Gocovri | $17 |
| GlaxoSmithKline | Meals · 2025-02-26 | Nucala | $29 |
| Merz Pharmaceuticals | Meals · 2025-01-13 | Xeomin | $46 |
| Axogen | Meals · 2025-01-04 | None | $119 |
See earlier years (2024, 2023, 2022)
2024: $5,051
| Aerin Medical | Vivaer Stylus | $3,789 | 17 payments
|
| Stryker | Scopis Ent | $641 | 4 payments
|
| Medtronic | Propel | $197 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $157 | 2 payments
|
| GlaxoSmithKline | None | $79 | 1 payment
|
| Genzyme | Dupixent | $73 | 3 payments
|
| Optinose US | Xhance | $66 | 3 payments
|
| Ipsen Biopharmaceuticals | Dysport | $34 | 1 payment
|
| Axogen | Avance Nerve Graft | $15 | 1 payment
|
2023: $542
| Aerin Medical | Vivaer Stylus | $321 | 2 payments
|
| Merz Pharmaceuticals | Xeomin | $133 | 1 payment
|
| Stryker | Xpress Ent Dilation System | $52 | 1 payment
|
| GlaxoSmithKline | Nucala | $20 | 1 payment
|
| Smith+Nephew | Grafix Pl | $16 | 1 payment
|
2022: $351
| Stryker | Xpress Ent Dilation System | $183 | 3 payments
|
| GlaxoSmithKline | Nucala | $99 | 1 payment
|
| Aerin Medical | None | $39 | 1 payment
|
| Medtronic | Mazor X System | $30 | 1 payment
|
Professional record
- NPI
- 1467108647
- Licence
- CA A176533California A176533: Current · expires 2028-02-29
- Trained
- Un of British Columbia, Faculty of Medicine, 2015
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2022-02-25
- NPI last updated
- 2024-01-25
- NPI record certified
- 2024-01-25
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305